Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits an anticancer effect in esophageal adenocarcinoma in vitro and in vivo

DOI IR Web Site 34 References
  • Watanabe Nobuyuki
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Takaoka Munenori
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Sakurama Kazufumi
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Tomono Yasuko
    Shigei Medical Research Institute
  • Hatakeyama Shinji
    Tsukuba Research Institute, Novartis Pharma K.K.
  • Ohmori Osamu
    Tsukuba Research Institute, Novartis Pharma K.K.
  • Motoki Takayuki
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Shirakawa Yasuhiro
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Yamatsuji Tomoki
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Haisa Minoru
    Department of Surgery, Okayama Citizens' Hospital
  • Matsuoka Junji
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Beer David G.
    Department of Surgery, Section of Thoracic Surgery, University of Michigan Medical School
  • Nagatsuka Hitoshi
    Department of Oral Pathology and Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Tanaka Noriaki
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
  • Naomoto Yoshio
    Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Bibliographic Information

Other Title
  • Ｆｏｃａｌ　ａｄｈｅｓｉｏｎ　ｋｉｎａｓｅ　（ＦＡＫ）　と　Ｉｎｓｕｌｉｎ－ｌｉｋｅ　ｇｒｏｗｔｈ　ｆａｃｔｏｒ－Ｉ　ｒｅｃｅｐｔｏｒ　（ＩＧＦ－ＩＲ）　に対するデュアルチロシンキナーゼ阻害剤の食道腺癌における抗腫瘍効果
  • 平成20年度岡山医学会賞(林原賞)受賞論文 Focal Adhesion Kinase(FAK)とInsulin-like growth factor-1 receptor(IGF-IR)に対するデュアルチロシンキナーゼ阻害剤の食道腺癌における抗腫瘍効果
  • ヘイセイ 20ネンド オカヤマ イガッカイショウ ハヤシバラショウ ジュショウ ロンブン Focal Adhesion Kinase FAK ト Insulin like growth factor 1 receptor IGF IR ニ タイスル デュアルチロシンキナーゼ ソガイザイ ノ ショクドウセンガン ニ オケル コウシュヨウ コウカ

Search this article

Journal

References(34)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top